A new study has put an end to misconceptions surrounding the use of paracetamol during pregnancy. Contrary to Donald Trump's claims last year, the comprehensive review of 43 studies found no link between taking paracetamol in pregnancy and an increased risk of autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), or intellectual disability.
The Lancet Obstetrics, Gynaecology and Women's Health published the study, which analyzed data from over 262,000 children assessed for ASD, 335,255 for ADHD, and 406,681 for intellectual disability. The researchers, led by Professor Asma Khalil of City St George's University of London, concluded that paracetamol use during pregnancy does not pose a significant risk to the child.
The study's findings are reassuring for expectant mothers who were previously anxious about using paracetamol due to Trump's baseless claims. The researchers emphasize that paracetamol remains a safe option for pregnant women when taken as directed, and that avoiding it may expose both mother and baby to unnecessary risks.
Experts have welcomed the study, stating that it brings an end to the speculation surrounding paracetamol use during pregnancy. Grainne McAlonan, Professor of Translational Neuroscience at King's College London, hopes that the findings will alleviate stress for expectant mothers who were previously uncertain about using paracetamol.
The study also highlights the importance of considering underlying health conditions rather than medications when assessing neurodevelopmental outcomes. Dr Steven Kapp, Senior Lecturer in Psychology at the University of Portsmouth, noted that society should focus on making the world a better place for disabled people rather than perpetuating false prevention measures.
Health Secretary Wes Streeting has reiterated the safety of paracetamol during pregnancy, advising women to ignore Trump's claims and rely on trusted medical advice.
The Lancet Obstetrics, Gynaecology and Women's Health published the study, which analyzed data from over 262,000 children assessed for ASD, 335,255 for ADHD, and 406,681 for intellectual disability. The researchers, led by Professor Asma Khalil of City St George's University of London, concluded that paracetamol use during pregnancy does not pose a significant risk to the child.
The study's findings are reassuring for expectant mothers who were previously anxious about using paracetamol due to Trump's baseless claims. The researchers emphasize that paracetamol remains a safe option for pregnant women when taken as directed, and that avoiding it may expose both mother and baby to unnecessary risks.
Experts have welcomed the study, stating that it brings an end to the speculation surrounding paracetamol use during pregnancy. Grainne McAlonan, Professor of Translational Neuroscience at King's College London, hopes that the findings will alleviate stress for expectant mothers who were previously uncertain about using paracetamol.
The study also highlights the importance of considering underlying health conditions rather than medications when assessing neurodevelopmental outcomes. Dr Steven Kapp, Senior Lecturer in Psychology at the University of Portsmouth, noted that society should focus on making the world a better place for disabled people rather than perpetuating false prevention measures.
Health Secretary Wes Streeting has reiterated the safety of paracetamol during pregnancy, advising women to ignore Trump's claims and rely on trusted medical advice.